USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
8 - 11 Oct 2023 | Las Vegas

The Climate-Health Imperative: A Call to Action for Health Care and Biomedicine

Keep exploring for FREE!

Create a free account or log in to unlock content, event past recordings and more!

Speakers:

Darla Silva Chief Program OfficerUNICEF USA
Darla Silva
Chief Program OfficerUNICEF USA
Leana Wen ColumnistThe Washington Post
Leana Wen
ColumnistThe Washington Post
Lloyd Minor DeanStanford School of Medicine
Lloyd Minor
DeanStanford School of Medicine

About this Session:

15.1 million Americans are eligible for lung cancer screening, but fewer than 1 million get screened annually with a low-dose CT (that's less than 6%!). DELFI Diagnostics is purpose-built to solve the highest-burden population health issues, starting with lung cancer. Join Victor Velculescu, M.D., Ph.D., DELFI's CEO, as he unveils the company's breakthrough test to help detect cancer at population scale. How? The science of fragmentomics is a remarkable discovery -- when cancer cells die, they shed DNA fragments into the bloodstream that are shaped more haphazardly than those from normal cells. DELFI's advanced machine learning technology identifies these genome-wide DNA fragment patterns and characteristics to spot signs of cancer in their earliest stages. This platform is poised to help drive one of the greatest public health goals of our lifetime--how to make a measurable impact in reducing cancer deaths through accurate, early detection.


Speaker: Victor Velculescu, M.D., Ph.D., CEO and Founder @ DELFI Diagnostics